Results for Phase I/II

Publications & Outputs

1. AGILE-ACCORD: A Randomized, Multicentre, Seamless, Adaptive Phase I/II Platform Study to Determine the Optimal Dose, Safety and Efficacy of Multiple Candidate Agents for the Treatment of COVID-19: A structured summary of a study protocol for a randomised platform trial

   UK NIHR Community, 19/06/2020, In: Trials. 21, 1, 3 p., 544.

   Research output: Contribution to Journal/Magazine › Journal article › peer-review